《生命科学》 2023, 35(12): 1652-1659
免疫检查点LAG-3在抗肿瘤免疫治疗中的研究进展
摘 要:
淋巴细胞活化基因-3 (LAG-3) 是继程序性死亡受体-1 (PD-1) 和细胞毒性T 淋巴细胞相关蛋白4(CTLA-4) 之后的又一热门免疫检查点,LAG-3 能通过多种途径调节免疫系统功能,如LAG-3 可调节T 细胞的耗竭、活化和肿瘤识别杀伤能力,调节Treg 细胞的免疫等。该文综述LAG-3 在免疫细胞调节中的功能和机制,及其参与抗肿瘤治疗及药物研发的进展,为LAG-3 作为靶点的临床应用和药物研发提供启示。
通讯作者:刘 松 , Email:songliu@gdpu.edu.cn
Abstract:
After programmed death receptor-1 (PD-1) and cytotoxic T lymphocyte associated protein 4 (CTLA-4), the lymphocyte activation gene-3 (LAG-3) is becoming a more and more popular immune checkpoint. LAG-3 regulates immune system through different signaling pathways. For example, LAG-3 regulates the exhaust, activation, and tumor recognition and killing ability of T cells, as well as the cellular immunity of Treg cells. Here, the function and mechanism of LAG-3 in regulating immune cells, its progress on antitumor immunotherapy and drug development were reviewed, which may provide reference for the LAG-3 based clinical application and drug development.
Communication Author:LIU Song , Email:songliu@gdpu.edu.cn